Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IMP4 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | CNOT6 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | GOSR2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | ORC2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | LTBR | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | KRTAP1-5 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
mRNA | ZC3H12D | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | MYADM | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | PAXBP1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | RPL7L1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |